Almost 15% increase in number of successful pharmacy degree applicants There were 5,240 people accepted onto an MPharm course in 2025, up 14.7% from the 4,570 acceptances in 2024.…
How has the pharmacy sector grown in 2025? From the NHS ten-year health plan to the best pharmacy contract in a decade, 2025 has been a newsworthy year for the sector. Here, scroll down to read the most significant headlines from the past 12 months.…
A patient’s sex may influence best choice of fracture medication, study finds Researchers found that males demonstrated an association between bisphosphonate use and risk of subsequent fracture, but females did not.…
GPhC receives ‘highest ever recorded’ number of concerns The majority of the concerns received by the General Pharmaceutical Council in the second quarter of 2025/2026 related to customer service issues and dispensing errors.…
Seven ways pharmacy can improve outcomes for those impacted by substance use Practical examples of and advice on how pharmacists can improve the care of individuals impacted by substance use. …
NICE threshold increase must not hit generics market, Lords told In a letter sent to Baroness Morris, pharmacy leaders recommended a review of the role of drug tariff pricing and retained margins to lower the number of medicines supplied to the NHS at a loss.…
What will 2026 hold for pharmacy? In this special episode of The PJ Pod, The Pharmaceutical Journal’s editorial team share their predictions for the year ahead.…
One in six patients with severe frailty received a medication review in 2024/2025 The National Audit Office has called for NHS England to set out clear and consistent GP requirements that involve the proportion and frequency of assessments for patients living with frailty.…
Health news round-up: the year in health across England, Scotland and Wales A weekly summary of important developments in health news, with summaries from each of the Welsh, Scottish and English chief medical officers’ annual reports.…
All patients should undergo pharmacogenetic testing before being prescribed clopidogrel The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics has highlighted that a significant proportion of the UK population have lower CYP2C19 enzyme levels, which lower the effectiveness of the antiplatelet drug.…
